Antithymocyte Globulin May Reduce Chronic Graft versus Host Disease in Patients Undergoing Unrelated Peripheral Stem Cell Transplantation

Publisher： Karger

E-ISSN： 2296-5262|22|6|519-519

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.22, Iss.6, 2000-01, pp. : 519-519

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

No indication of increased infection rates using low‐dose alemtuzumab instead of anti‐thymocyte globulin as graft‐versus‐host disease prophylaxis before allogeneic stem cell transplantation

By  

TRANSPLANT INFECTIOUS DISEASE (ELECTRONIC), Vol. 20, Iss. 1, 2018-02 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

A Case of Acute Graft‐versus‐Host Disease Following Autologous Peripheral Blood Stem Cell Transplantation

By  

THE JOURNAL OF DERMATOLOGY, Vol. 27, Iss. 7, 2000-07 ,pp. : 446-449

John Wiley & Sons Inc

Access to resources Recommend Favorite

The efficacy and safety of sirolimus‐based graft‐versus‐host disease prophylaxis in patients undergoing allogeneic hematopoietic stem cell transplantation: a meta‐analysis of randomized controlled trials

By  

TRANSFUSION, Vol. 41-1132, Iss. 9, 2015-09 ,pp. : 2134-2141

John Wiley & Sons Inc

Access to resources Recommend Favorite

The efficacy and safety of sirolimus‐based graft‐versus‐host disease prophylaxis in patients undergoing allogeneic hematopoietic stem cell transplantation: a meta‐analysis of randomized controlled trials

By  

TRANSFUSION, Vol. 55, Iss. 9, 2015-09 ,pp. : 2134-2141

John Wiley & Sons Inc

Access to resources Recommend Favorite

Experience with anidulafungin in patients with allogeneic hematopoietic stem cell transplantation and graft‐versus‐host disease

By  

TRANSPLANT INFECTIOUS DISEASE (ELECTRONIC), Vol. 1398-2273, Iss. 5, 2015-10 ,pp. : 761-767

John Wiley & Sons Inc

Access to resources Recommend Favorite